- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy ; volume:22 ; number:1 ; day:5 ; month:8 ; year:2024 ; pages:1-43 ; date:12.2024
Journal of translational medicine ; 22, Heft 1 (5.8.2024), 1-43, 12.2024
- Urheber
-
Mohammad Taheri, Mohadeseh
Javan, Fatemeh
Poudineh, Mohadeseh
Athari, Seyed Shamseddin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-024-05534-8
- URN
-
urn:nbn:de:101:1-2410252103589.641944886114
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mohammad Taheri, Mohadeseh
- Javan, Fatemeh
- Poudineh, Mohadeseh
- Athari, Seyed Shamseddin
- SpringerLink (Online service)
Ähnliche Objekte (12)
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
Nanobody-based CAR-T cells for cancer immunotherapy
Breakthrough of solid tumor treatment: CAR-NK immunotherapy
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany
Engineering CAR-T cells
Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer
Visualizing CAR-T cell Immunotherapy Using 3 Tesla Fluorine-19 MRI
CAR-NK cells for cancer immunotherapy: from bench to bedside
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study
Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
Nanobody-based CAR-T cells for cancer immunotherapy
Breakthrough of solid tumor treatment: CAR-NK immunotherapy
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany
Engineering CAR-T cells
Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer
Visualizing CAR-T cell Immunotherapy Using 3 Tesla Fluorine-19 MRI
CAR-NK cells for cancer immunotherapy: from bench to bedside
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study
Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
Nanobody-based CAR-T cells for cancer immunotherapy
Breakthrough of solid tumor treatment: CAR-NK immunotherapy
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany
Engineering CAR-T cells
Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer
Visualizing CAR-T cell Immunotherapy Using 3 Tesla Fluorine-19 MRI
CAR-NK cells for cancer immunotherapy: from bench to bedside
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study